Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

NCT02680002 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
422
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

Biomedical Advanced Research and Development Authority

Collaborators